Illinois Hospital Report Card

and Consumer Guide to Health Care

Advocate Lutheran General Hospital

Patient Safety - CDI & MRSA

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2024 - Q4 2024 Result 4 infections, 211414 patient days Rating SIR: 0.25	4 infections, 211414 patient days	0.25
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 9 infections, 202640 patient days Rating SIR: 0.59	9 infections, 202640 patient days	0.59
Q1 2022 - Q4 2022 Result 8 infections, 199570 patient days Rating SIR: 0.53	8 infections, 199570 patient days	0.53
Q1 2021 - Q4 2021 Result 9 infections, 182672 patient days Rating SIR: 0.65	9 infections, 182672 patient days	0.65
Q1 2020 - Q4 2020 Result 7 infections, 157349 patient days Rating SIR: 0.59	7 infections, 157349 patient days	0.59
Q1 2019 - Q4 2019 Result 7 infections, 165217 patient days Rating SIR: 0.71	7 infections, 165217 patient days	0.71
Q1 2018 - Q4 2018 Result 5 infections, 164449 patient days Rating SIR: 0.46	5 infections, 164449 patient days	0.46
Q1 2017 - Q4 2017 Result 5 infections, 146952 patient days Rating SIR: 0.82	5 infections, 146952 patient days	0.82
Q1 2016 - Q4 2016 Result 4 infections, 148079 patient days Rating SIR: 0.53	4 infections, 148079 patient days	0.53
Q1 2015 - Q4 2015 Result 5 infections, 157929 patient days Rating SIR: 0.60	5 infections, 157929 patient days	0.60
Q1 2014 - Q4 2014 Result 7 infections, 167202 patient days Rating SIR: 0.70	7 infections, 167202 patient days	0.70
Q1 2013 - Q4 2013 Result 0 infections, 165439 patient days Rating SIR: 0.00	0 infections, 165439 patient days	0.00
Q1 2012 - Q4 2012 Result 3 infections, 166624 patient days Rating SIR: 0.29	3 infections, 166624 patient days	0.29
Q1 2012 - Q2 2012 Result 1 infections, 86233 patient days Rating SIR: 0.12	1 infections, 86233 patient days	0.12
Clostridioides difficile infections (CDI) Q1 2024 - Q4 2024 Result 47 infections, 188864 patient days Rating SIR: 0.48	47 infections, 188864 patient days	0.48
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 44 infections, 181009 patient days Rating SIR: 0.47	44 infections, 181009 patient days	0.47
Q1 2022 - Q4 2022 Result 67 infections, 178307 patient days Rating SIR: 0.73	67 infections, 178307 patient days	0.73
Q1 2021 - Q4 2021 Result 59 infections, 164661 patient days Rating SIR: 0.68	59 infections, 164661 patient days	0.68
Q1 2020 - Q4 2020 Result 44 infections, 139680 patient days Rating SIR: 0.61	44 infections, 139680 patient days	0.61
Q1 2019 - Q4 2019 Result 39 infections, 144855 patient days Rating SIR: 0.57	39 infections, 144855 patient days	0.57
Q1 2018 - Q4 2018 Result 120 infections, 144789 patient days Rating SIR: 1.25	120 infections, 144789 patient days	1.25
Q1 2017 - Q4 2017 Result 113 infections, 127160 patient days Rating SIR: 1.27	113 infections, 127160 patient days	1.27
Q1 2016 - Q4 2016 Result 126 infections, 127556 patient days Rating SIR: 1.39	126 infections, 127556 patient days	1.39
Q1 2015 - Q4 2015 Result 92 infections, 135835 patient days Rating SIR: 0.87	92 infections, 135835 patient days	0.87
Q1 2014 - Q4 2014 Result 88 infections, 144408 patient days Rating SIR: 0.74	88 infections, 144408 patient days	0.74
Q1 2013 - Q4 2013 Result 71 infections, 143427 patient days Rating SIR: 0.60	71 infections, 143427 patient days	0.60
Q1 2012 - Q4 2012 Result 99 infections, 144639 patient days Rating SIR: 0.84	99 infections, 144639 patient days	0.84